Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis
AM McEvoy, K Lachance, DS Hippe, K Cahill… - JAMA …, 2022 - jamanetwork.com
Importance Merkel cell carcinoma (MCC) often behaves aggressively; however, disease-
recurrence data are not captured in national databases, and it is unclear what proportion of
patients with MCC experience a recurrence (estimates vary from 27%-77%). Stage-specific
recurrence data that includes time from diagnosis would provide more precise prognostic
information and contribute to risk-appropriate clinical surveillance. Objective To estimate risk
of stage-specific MCC recurrence and mortality over time since diagnosis. Design, Setting …
recurrence data are not captured in national databases, and it is unclear what proportion of
patients with MCC experience a recurrence (estimates vary from 27%-77%). Stage-specific
recurrence data that includes time from diagnosis would provide more precise prognostic
information and contribute to risk-appropriate clinical surveillance. Objective To estimate risk
of stage-specific MCC recurrence and mortality over time since diagnosis. Design, Setting …